This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Eisai R&d Management Co., Ltd., Eisai Company, Limited. Active years: 2007-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007-2010
Title: Fabian Gusovksy: Innovator in Toll-like Receptor Research
Introduction
Fabian Gusovksy is a notable inventor based in Andover, MA (US). He has made significant contributions to the field of medical research, particularly in the area of compounds and methods for treating diseases related to Toll-like receptor 2 activation. With a total of 3 patents to his name, Gusovksy has established himself as a key figure in his domain.
Latest Patents
Gusovksy's latest patents focus on innovative approaches to treating Toll-like receptor 2-related diseases and conditions. The first patent details compounds and methods that are useful in the prevention or treatment of diseases associated with Toll-like receptor 2 activation. This invention aims to provide new therapeutic options for patients suffering from these conditions. The second patent reiterates similar themes, emphasizing the importance of these compounds in addressing health issues linked to Toll-like receptor 2.
Career Highlights
Throughout his career, Gusovksy has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Eisai R&D Management Co., Ltd. and Eisai Company, Limited. His work in these organizations has allowed him to contribute to groundbreaking research and development efforts.
Collaborations
Gusovksy has collaborated with several professionals in his field, including Jesse Chow and Lynn D Hawkins. These partnerships have likely enhanced his research and innovation capabilities, leading to the successful development of his patents.
Conclusion
Fabian Gusovksy is a distinguished inventor whose work in Toll-like receptor research has the potential to impact the treatment of various diseases. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

